#immunotech — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #immunotech, aggregated by home.social.
-
https://www.europesays.com/britain/58501/ AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer #(rintatolimod) #2 #AIM #Ampligen® #AstraZeneca #Astrazeneca's #Cancer #Clinical #combination #durvalumab #Evaluating #for #from #Imfinzi #ImmunoTech #in #Interim #MidYear #of #Pancreatic #Phase #Positive #Progress #reports #Study #the #Treatment #with